Journal of Animal and Veterinary Advances

Year: 2015
Volume: 14
Issue: 13
Page No. 374 - 381

Design, Synthesis, SAR and Anti-Breast Cancer Potential of New Thymoquinone Analogs as PPARγ Ligands

Authors : N.H. Mohammed, M.I. Mostafa and A.Y. AL-Taher

References

Altiok, S., M. Xu and B.M. Spiegelman, 1997. PPAR γ induces cell cycle withdrawal: Inhibition of E2F-DP DNA-binding activity via down-regulation of PP2A. Genes Dev., 11: 1987-1998.
CrossRef  |  Direct Link  |  

Azukizawa, S., M. Kasai, K. Takahashi, T. Miike and K. Kunishiro et al., 2008. Synthesis and biological evaluation of (S)-1, 2, 3, 4-tetrahydroisoquinoline-3-carboxylic Acids: A novel series of PPAR. GAMMA. Agonists. Chem. Pharm. Bull., 56: 335-345.
Direct Link  |  

Banerjee, S., A.S. Azmi, S. Padhye, M.W. Singh and J.B. Baruah et al., 2010. Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer. Pharm. Res., 27: 1146-1158.
CrossRef  |  Direct Link  |  

Cobb, J.E., S.G. Blanchard, E.G. Boswell, K.K. Brown and P.S. Charifson et al., 1998. N-(2-benzoylphenyl)-L-tyrosine PPAR γ agonists: 3 Structure-activity relationship and optimization of the N-aryl substituent. J. Med. Chem., 41: 5055-5069.
CrossRef  |  Direct Link  |  

Collins, J.L., S.G. Blanchard, G.E. Boswell, P.S. Charifson and J.E. Cobb et al., 1998. N-(2-Benzoylphenyl)-L-tyrosine PPARγ agonists: 2 Structure-activity relationship and optimization of the phenyl alkyl ether moiety. J. Med. Chem., 41: 5037-5054.
CrossRef  |  Direct Link  |  

Demetri, G.D., C.D. Fletcher, E. Mueller, P. Sarraf and R. Naujoks et al., 1999. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma. Proc. National Acad. Sci., 96: 3951-3956.
CrossRef  |  Direct Link  |  

Deroo, B.J. and K.S. Korach, 2006. Estrogen receptors and human disease. J. Clin. Invest., 116: 561-570.
CrossRef  |  

Fenner, M.H. and E. Elstner, 2005. Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer. Expert Opin. Invest. Drugs, 14: 557-568.
Direct Link  |  

Gali-Muhtasib, H., A. Roessner and R. Shneider-Stock, 2006. Thymoquinone: A promising anti-cancer drug from natural sources. Intl. J. Biochem. Cell Biol., 38: 1249-1253.
CrossRef  |  Direct Link  |  

Ghorab, M.M., A.N. Osman, E. Noaman, H.I. Heiba and N.H. Zaher, 2006. The synthesis of some new sulfur heterocyclic compounds as potential radioprotective and anticancer agents. Phosphorus Sulfur Silicon Relat. Ele., 181: 1935-1950.
Direct Link  |  

Vallve, S.G. and J. Palau, 1998. Nuclear receptors, nuclear-receptor factors and nuclear-receptor-like orphans form a large paralog cluster in Homo sapiens. Mol. Biol. Evol., 15: 665-682.
Direct Link  |  

Woo, C.C., A.P. Kumar, G. Sethi and K.H.B. Tan, 2012. Thymoquinone: Potential cure for inflammatory disorders and cancer. Biochem. Pharmacol., 83: 443-451.
CrossRef  |  Direct Link  |  

Design and power by Medwell Web Development Team. © Medwell Publishing 2024 All Rights Reserved